Who are EmVenio's investors?

EmVenio's investors include Reno Seed Fund.

How much funding has EmVenio raised?

EmVenio has disclosed $9.2M raised across 1 round.

Where is EmVenio headquartered?

EmVenio is headquartered in Sparks, US.

EmVenio

Sparks, US · Founded 2022 · 1 known investors

Find your way into EmVenio

424 people in our graph share verified history with the EmVenio team — schools, employers, funds. One of them is your warm intro.

Michael Balmuthunlockedknows Jeff Huntsman · together at Citeline (overlapped)

×5knows the team · via Clarivate

×2knows the team · via Zayo Group

×3knows the team · via PAREXEL

knows the team · via Warburg Pincus

EmVenio runs decentralized clinical research through in-home patient visits, community-based research sites, and patient navigation services, helping trial sponsors and CROs reach underrepresented populations. It supports clinical trial recruitment, retention, and data capture across more than 90 countries.

Biotech Digital Health Enterprise Software Healthtech

Founders & leadership

Greg Austin Greg Austin has served as President of Professional Case Management and EmVenio since 2005, leading a large team in decentralized clinical research and patient care services.

Mark McKenzieM.D.

Jeff Huntsman Jeff Huntsman leads EmVenio, a decentralized clinical research platform serving trial sponsors and CROs. He previously held commercial and executive leadership roles focused on sales strategy, business development, and organizational growth in pharmaceutical, healthcare technology, and SaaS sectors.

Tajuana BarronFounder

Tom O'Connor Tom O'Connor has held leadership roles spanning home healthcare, clinical research, and telecommunications, with expertise in decentralized clinical trials and international market expansion across both startups and established companies.

Christy Crase

Thaddeus WolframNamed on SEC filing

Monty WaughNamed on SEC filing

Alan HenthorneNamed on SEC filing

Daniel CastilloNamed on SEC filing

David ShackeltonNamed on SEC filingInvestor at Reno Seed Fund

Charlie Billings

Investors · 1

Reno Seed Fundlisted by Reno Seed FundReno

Reported raises · per SEC filings

Form D private placements

$9.2M disclosed across 1 round · 2022

▶$9.2MraisedDec 2022 · 23 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Thaddeus WolframExecutive Officer
Monty WaughExecutive Officer
Alan HenthorneExecutive Officer, Director
Daniel CastilloExecutive Officer
David ShackeltonExecutive Officer, Director

Offering amount: $10M
Amount sold: $9.2M
Minimum investment: $50K
First sale: Aug 2022
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does EmVenio do?: EmVenio runs decentralized clinical research through in-home patient visits, community-based research sites, and patient navigation services, helping trial sponsors and CROs reach underrepresented populations. It supports clinical trial recruitment, retention, and data capture across more than 90 countries.
Who are EmVenio's investors?: EmVenio's investors include Reno Seed Fund.
How much funding has EmVenio raised?: EmVenio has disclosed $9.2M raised across 1 round.
Where is EmVenio headquartered?: EmVenio is headquartered in Sparks, US.